Rutherford Health

Nostos Genomics, PrecisionLife
Roundup: Nostos Genomics raises €5M to speed up genetic disease diagnosis, Canary's rapid test achieves CE mark, and more briefs
By Tammy Lovell | 11:24 am | February 04, 2022
Plus, PrecisionLife announces first close of Series A financing to progress drug discovery.
New frontiers of AI and data analytics in oncology
By HIMSS TV | 09:08 am | May 12, 2021
Rutherford Health Chief Medical Officer Karol Sikora highlights the most pressing needs in cancer treatment today and how he envisages treatment decision-making in the next decade.